Andrew Krakauer (Insider Trades), CEO of Cantel Medical Corp. (CMN), sold 22,981 shares of the company on Oct. 14. The per share was $54.22 for a total transaction of $1,246,030. Cantel Medical Corp. delivers infection prevention and control product and services for patients, caregivers, and other healthcare providers, which improve outcomes, enhance safety and help save lives. The company has a market cap of $2.23 billion and a P/S ratio of 4.02.
The number of insider sells ranged from 14 to 19 during 2012 to 2015. The volume of insider buys decreased by about 60% during the same period of time. There were 18 insider sells with the company in 2012, totaling 682,227 shares. In comparison, there were 19 insider sells of CMN totaling 210,821 shares in 2015. The month end price increased about three-fold during this time. Krakauer sold 384,925 shares of the company in 11 transactions since April 2010. The value increased about 800% since the sell. Director Ann Berman (Insider Trades) also sold 2,462 shares of the company on Oct. 5. The average price per share was $56.67. Additionally, CMN Chairman and 10% owner, Charles Diker (Insider Trades), also sold 27,415 shares three days before Berman. The average price per share was $56.24. For more information about insider transaction with the company, click here. Continue Reading »